Thoracic Oncology, Lung Unit, P. Pederzoli Hospital, Peschiera Del Garda, VR, Italy.
Respiratory Department, Northumbria Health Care NHS Foundation Trust, Care of Gail Hewitt, Newcastle NE23 6NZ, UK.
Curr Oncol. 2024 Aug 27;31(9):4968-4983. doi: 10.3390/curroncol31090368.
Ranked high in worldwide growing health issues, pleural diseases affect approximately one million people globally per year and are often correlated with a poor prognosis. Among these pleural diseases, malignant pleural mesothelioma (PM), a neoplastic disease mainly due to asbestos exposure, still remains a diagnostic challenge. Timely diagnosis is imperative to define the most suitable therapeutic approach for the patient, but the choice of diagnostic modalities depends on operator experience and local facilities while bearing in mind the yield of each diagnostic procedure. Since the analysis of pleural fluid cytology is not sufficient in differentiating historical features in PM, histopathological and morphological features obtained via tissue biopsies are fundamental. The quality of biopsy samples is crucial and often requires highly qualified expertise. Since adequate tissue biopsy is essential, medical or video-assisted thoracoscopy (MT or VATS) is proposed as the most suitable approach, with the former being a physician-led procedure. Indeed, MT is the diagnostic gold standard for malignant pleural pathologies. Moreover, this medical or surgical approach can allow diagnostic and therapeutic procedures: it provides the possibility of video-assisted biopsies, the drainage of high volumes of pleural fluid and the administration of sterile calibrated talcum powder under visual control in order to achieve pleurodesis, placement of indwelling pleural catheters if required and in a near future potential intrapleural therapy. In this context, dedicated diagnostic pathways remain a crucial need, especially to quickly and properly diagnose PM. Lastly, the interdisciplinary approach and multidisciplinary collaboration should always be implemented in order to direct the patient to the best customised diagnostic and therapeutic pathway. At the present time, the diagnosis of PM remains an unsolved problem despite MDT (multidisciplinary team) meetings, mainly because of the lack of standardised diagnostic work-up. This review aims to provide an overview of diagnostic procedures in order to propose a clear strategy.
在全球日益严重的健康问题中,胸膜疾病的发病率位居前列,全球每年约有 100 万人受到影响,且常常预后不良。在这些胸膜疾病中,恶性胸膜间皮瘤(MPM)是一种主要由石棉暴露引起的肿瘤性疾病,仍然是一个诊断难题。及时诊断对于为患者确定最合适的治疗方法至关重要,但诊断方式的选择取决于操作者的经验和当地的医疗条件,同时还要考虑每种诊断程序的效果。由于胸膜液细胞学分析不足以区分间皮瘤的历史特征,因此组织活检获得的组织病理学和形态学特征是基本的。活检样本的质量至关重要,通常需要高度专业的知识。由于获得足够的组织活检至关重要,因此医学或电视辅助胸腔镜(MT 或 VATS)被提议作为最合适的方法,前者是由医生主导的程序。实际上,MT 是恶性胸膜病变的诊断金标准。此外,这种医疗或手术方法可以进行诊断和治疗操作:它提供了在可视控制下进行视频辅助活检、引流大量胸腔积液和施用无菌校准滑石粉的可能性,以实现胸膜固定术,如果需要,还可以放置留置胸腔导管,并在不久的将来进行潜在的腔内治疗。在这种情况下,专门的诊断途径仍然是一个关键需求,特别是为了快速、正确地诊断间皮瘤。最后,应该始终实施跨学科方法和多学科合作,以便为患者提供最佳的个性化诊断和治疗途径。目前,尽管有 MDT(多学科团队)会议,但间皮瘤的诊断仍然是一个悬而未决的问题,主要是因为缺乏标准化的诊断程序。本综述旨在概述诊断程序,以提出明确的策略。